EMEA-001600-PIP01-13-M02

Key facts

Active substance
Olipudase alfa
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0459/2020
PIP number
EMEA-001600-PIP01-13-M02
Pharmaceutical form(s)
Powder for solution for injection or infusion
Condition(s) / indication(s)
Treatment of Niemann-Pick disease
Route(s) of administration
Intravenous use
Contact for public enquiries
Genzyme Europe B.V.

Email: Contact-US@sanofi.com
Tel. +33 169745695 
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating